Speciallægeselskabet Katrine Lund Nørgaard ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  0.0% 8.5% 4.2% 4.7% 6.1%  
Credit score (0-100)  0 27 48 44 38  
Credit rating  N/A BB BBB BBB BBB  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -96.0 1,758 3,244 3,072  
EBITDA  0.0 -839 194 870 819  
EBIT  0.0 -1,137 -313 157 94.0  
Pre-tax profit (PTP)  0.0 133.4 143.4 19.5 -43.9  
Net earnings  0.0 80.7 94.0 14.9 -34.4  
Pre-tax profit without non-rec. items  0.0 133 143 19.5 -43.9  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 416 646 584 437  
Shareholders equity total  0.0 121 158 114 18.2  
Interest-bearing liabilities  0.0 1,866 4,167 3,492 2,815  
Balance sheet total (assets)  0.0 2,123 4,603 3,893 3,149  

Net Debt  0.0 1,782 4,167 3,492 2,808  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -96.0 1,758 3,244 3,072  
Gross profit growth  0.0% 0.0% 0.0% 84.5% -5.3%  
Employees  0 1 3 6 6  
Employee growth %  0.0% 0.0% 200.0% 100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 2,123 4,603 3,893 3,149  
Balance sheet change%  0.0% 0.0% 116.9% -15.4% -19.1%  
Added value  0.0 -838.6 193.9 663.2 818.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 1,505 1,747 -1,354 -1,449  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 1.0 2.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 1,184.7% -17.8% 4.8% 3.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 8.1% 6.4% 3.7% 2.7%  
ROI %  0.0% 8.6% 6.7% 3.9% 2.9%  
ROE %  0.0% 66.9% 67.6% 11.0% -52.2%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 5.7% 3.4% 2.9% 0.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -212.5% 2,149.1% 401.3% 343.0%  
Gearing %  0.0% 1,545.5% 2,645.2% 3,075.0% 15,508.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 4.2% 2.3% 3.6% 4.4%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.5 0.5 0.5 0.4  
Current Ratio  0.0 0.5 0.5 0.5 0.4  
Cash and cash equivalent  0.0 83.7 0.0 0.0 6.8  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -207.8 -491.9 -478.6 -553.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -839 65 111 136  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -839 65 145 136  
EBIT / employee  0 -1,137 -104 26 16  
Net earnings / employee  0 81 31 2 -6